Hua Medicine Investor Relations Material
Latest events
H2 2024
Hua Medicine
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Hua Medicine
Access all reports
Hua Medicine is a China-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for the treatment of metabolic diseases. The company specializes in drug candidates targeting type 2 diabetes and related conditions, leveraging internal research and clinical development capabilities. Hua Medicine conducts both domestic and international clinical trials and collaborates with academic and industry partners to advance its pipeline. The company is headquartered in Shanghai, China, and its shares are listed on the HKEX.
Key slides for Hua Medicine
H1 2024
Hua Medicine
H2 2024
Hua Medicine
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
2552
Country
🇭🇰 Hong Kong